Stay updated on Novel Therapeutics for High-Risk AML Clinical Trial

Sign up to get notified when there's something new on the Novel Therapeutics for High-Risk AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Novel Therapeutics for High-Risk AML Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The date has been updated from February 28, 2025, to March 5, 2025.
    Difference
    0.6%
    Check dated 2025-03-10T23:49:55.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The webpage has removed a notice regarding heavy traffic affecting certain services and products, as well as a specific date. Additionally, a new date has been added.
    Difference
    6%
    Check dated 2025-03-03T22:19:05.000Z thumbnail image
  3. Check
    24 days ago
    Change Detected
    Summary
    The date has been updated from February 7, 2025, to February 11, 2025.
    Difference
    0.3%
    Check dated 2025-02-17T14:46:05.000Z thumbnail image
  4. Check
    31 days ago
    Change Detected
    Summary
    The page now includes a notice about heavy traffic affecting NLM-NCBI services and products, along with a contact email for assistance. Additionally, a date has been updated from January 31, 2025, to February 7, 2025.
    Difference
    6%
    Check dated 2025-02-10T09:43:24.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    The website has been updated to version v2.14.2 on January 31, 2025, following the removal of version v2.14.1 on January 23, 2025.
    Difference
    0.6%
    Check dated 2025-02-03T07:34:58.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    New content was added on January 23, 2025, following the deletion of previous content on January 17, 2025.
    Difference
    0.3%
    Check dated 2025-01-27T03:24:14.000Z thumbnail image

Stay in the know with updates to Novel Therapeutics for High-Risk AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Novel Therapeutics for High-Risk AML Clinical Trial page.